Similar articles for PMID: 15161045

Year	Number of Results
1992	1
1995	2
1996	1
1997	1
1999	3
2000	4
2001	2
2002	3
2003	2
2004	3
2005	2
2006	6
2007	4
2008	4
2009	2
2010	5
2011	2
2012	1
2013	1
2014	2
2015	5
2016	5
2018	1
2019	1
2020	1
2024	0

1

Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer.

Gabriel B, Mildenberger S, Weisser CW, Metzger E, Gitsch G, Schüle R, Müller JM. Gabriel B, et al. Anticancer Res. 2004 Mar-Apr;24(2B):921-7. Anticancer Res. 2004. PMID: 15161045 Free article.

2

The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.

Kleiber K, Strebhardt K, Martin BT. Kleiber K, et al. Anticancer Res. 2007 Jan-Feb;27(1A):55-61. Anticancer Res. 2007. PMID: 17352216 Free article. Review.

3

Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.

Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, Chu PH, Chen J, Otey CA, Cao X, Cheng SL. Lai CF, et al. J Bone Miner Res. 2006 Jan;21(1):17-28. doi: 10.1359/JBMR.050915. Epub 2005 Oct 3. J Bone Miner Res. 2006. PMID: 16355270 Free article.

4

Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.

Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, Frame MC. Agochiya M, et al. Oncogene. 1999 Oct 7;18(41):5646-53. doi: 10.1038/sj.onc.1202957. Oncogene. 1999. PMID: 10523844

5

Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization.

Li HY, Kotaka M, Kostin S, Lee SM, Kok LD, Chan KK, Tsui SK, Schaper J, Zimmermann R, Lee CY, Fung KP, Waye MM. Li HY, et al. Cell Motil Cytoskeleton. 2001 Jan;48(1):11-23. doi: 10.1002/1097-0169(200101)48:1<11::AID-CM2>3.0.CO;2-I. Cell Motil Cytoskeleton. 2001. PMID: 11124707

6

Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein.

Sasaki H, Kotsuji F, Tsang BK. Sasaki H, et al. Gynecol Oncol. 2002 May;85(2):339-50. doi: 10.1006/gyno.2002.6632. Gynecol Oncol. 2002. PMID: 11972398

7

Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.

Wang C, Lv X, He C, Davis JS, Wang C, Hua G. Wang C, et al. Int J Mol Sci. 2020 Oct 20;21(20):7751. doi: 10.3390/ijms21207751. Int J Mol Sci. 2020. PMID: 33092075 Free PMC article.

8

pp125FAK in human melanocytes and melanoma: expression and phosphorylation.

Scott G, Liang H. Scott G, et al. Exp Cell Res. 1995 Jul;219(1):197-203. doi: 10.1006/excr.1995.1219. Exp Cell Res. 1995. PMID: 7543052 Free article.

9

Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.

Kollara A, Brown TJ. Kollara A, et al. Int J Biochem Cell Biol. 2009 May;41(5):1182-8. doi: 10.1016/j.biocel.2008.10.019. Epub 2008 Oct 28. Int J Biochem Cell Biol. 2009. PMID: 19015043

10

Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells.

Xiong Z, Ding L, Sun J, Cao J, Lin J, Lu Z, Liu Y, Huang C, Ye Q. Xiong Z, et al. IUBMB Life. 2010 Sep;62(9):669-76. doi: 10.1002/iub.367. IUBMB Life. 2010. PMID: 20734429 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year